Could Tumor Spread Through Air Spaces Identify Distinct Subgroup with Poor Prognosis in Lung Pleomorphic Carcinoma?

Tieniu Song,Yidan Lin
DOI: https://doi.org/10.1016/j.chest.2019.04.110
IF: 9.6
2019-01-01
Chest
Abstract:We read with great interest the study by Yokoyama et al1Yokoyama S. Murakami T. Tao H. et al.Tumor spread through air spaces identifies a distinct subgroup with poor prognosis in surgically resected lung pleomorphic carcinoma.Chest. 2018; 154: 838-847Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar in CHEST (October 2018). In the retrospective study, tumor spread through air spaces (STAS) in patients with lung pleomorphic carcinoma (PC) was associated with high recurrence rates and poor survival after surgical resection, and regarded as a predictor of postoperative survival. However, we would like to raise the following comments. In this study, lung PC was defined as a poorly differentiated non-small cell lung carcinoma comprising at least 10% spindle and/or giant cells, but pure spindle cell carcinomas or giant cell carcinomas were excluded. In other words, all cases contained identifiable epithelial components. Both coexisted epithelial components and histologic adenocarcinoma subtypes were not associated with STAS. However, the percentage of them was not clear in lung PC. When present in predominant pattern, aggressive micropapillary or solid components have a poor prognostic significance and are significantly associated with STAS.2Ma K. Zhan C. Wang S. et al.Spread through air spaces (STAS): a new pathologic morphology in lung cancer.Clin Lung Cancer. 2019; 20: e158-e162Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar STAS was also more frequent in aggressive squamous cell carcinoma.3Lu S. Tan K.S. Kadota K. et al.Spread through air spaces (STAS) is an independent predictor of recurrence and lung cancer-specific death in squamous cell carcinoma.J Thorac Oncol. 2017; 12: 223-234Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar Therefore, tumor cells within air spaces beyond the edge of the main tumor might be ascribed to epithelial components other than spindle and/or giant cells. Molecular studies and some clinicopathologic characteristics of PC supported sarcomatoid transformation from the epithelial component,4Mochizuki T. Ishii G. Nagai K. et al.Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases.Am J Surg Pathol. 2008; 32: 1727-1735Crossref PubMed Scopus (157) Google Scholar which accompanied epithelial cells losing their cell polarity and cell-cell adhesion and gaining the migratory and invasive properties.5Gloushankova N.A. Zhitnyak I.Y. Rubtsova S.N. Role of epithelial-mesenchymal transition in tumor progression.Biochemistry (Mosc). 2018; 83: 1469-1476Google Scholar Maybe STAS and sarcomatoid component were the outcomes during progression of poorly differentiated discohesive epithelial tumors, such as micropapillary or solid adenocarcinomas, and poorly differentiated squamous cell carcinoma. Therefore, tumor cells within air spaces should be further classified based on morphology, immunohistochemical stain, or molecular data. Otherwise, STAS in lung PC with poor prognosis might be because of concomitant poorly differentiated epithelial tumors. The number of patients was small in this study (N = 35). Overall survival should be calculated according to cancer-specific death rather than death because of any cause. Eight patients died during follow-up, and one patient (13%) died because of acute exacerbation of underlying interstitial pneumonia, which might affect the statistical result. In addition, adjuvant therapy was not demonstrated in this article. Some studies have reported that unresectable lung PC responds poorly to conventional chemotherapy, but always has a certain proportion of KRAS and EGFR mutations.6Travis W.D. Brambilla E. Nicholson A.G. et al.The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification.J Thorac Oncol. 2015; 10: 1243-1260Abstract Full Text Full Text PDF PubMed Scopus (2595) Google Scholar Comprehensive therapies including chemotherapy, radiotherapy, and especially KRAS and EGFR inhibitor therapies could affect overall survival to some extent. It was difficult to verify whether recurrent tumors satisfied the criteria of lung PC. The component of recurrent tumors cannot be assessed by CT scan, which might include merely epithelial or sarcomatoid cells. Furthermore, the stage of lung PC was not stratified completely in the statistical analysis. Maybe the number of patients in each stage could not satisfy the statistical requirements, so patients in stages I and II were combined. Therefore, larger series are required in further studies. In summary, PC in lung is rare. We should regard these conclusions from the small number of patients cautiously. More details in histopathologic evaluation and patient cohort should be reconsidered comprehensively in this study, which would greatly refine the conclusions. Tumor Spread Through Air Spaces Identifies a Distinct Subgroup With Poor Prognosis in Surgically Resected Lung Pleomorphic CarcinomaCHESTVol. 154Issue 4PreviewTumor spread through air spaces (STAS) has recently been reported as a novel form of lung adenocarcinoma invasion that can negatively affect survival; however, its role in pleomorphic carcinoma remains unclear. The goal of this study was to characterize tumor STAS in pleomorphic carcinoma, including its association with clinicopathologic features and prognosis. Full-Text PDF ResponseCHESTVol. 156Issue 3PreviewWe are grateful for the comments of Song and Lin on our publication regarding tumor spread through air spaces (STAS) in lung pleomorphic carcinoma (PC).1 They raised some valid concerns about our pathologic approach and statistical analysis. We appreciate their interest in our study, and our response to their concerns is as follows. Full-Text PDF
What problem does this paper attempt to address?